Recent Articles By The Author
Smith & Wesson's recent selloff was an overreaction. Here's how to take advantage of it.
I've scooped up shares of giant phosphate and potash concern Mosaic.
Small-cap biotech Marker Therapeutics and online appliance seller 1847 Goedeker have been beaten down lately but offer hope for bouncing back.
The sector is deep in a stealth bear market, but there are reasons for optimism heading into 2022.
TherapeuticsMD and Spark Networks are beaten-down names with recent buying interest from insiders in common.
Talos Energy and Occidental Petroleum are the energy producers that are worth a look.
It's hard to see how consumer spending won't be impacted by higher prices, which is something the market still might not be pricing into equities.